Published March 2022
Women in Science – webinar with Deborah O’Neil
11th February marks International Day of Women and Girls in Science and 8th March marks International Women’s Day. HGF is celebrating both days internally and externally and is running various activities throughout the month from 11th February to 8th March.
On 1st March we hosted a Women in Science webinar with Dr Deborah O’Neil OBE FRSE. Deborah is Chief Executive Officer and Scientific Officer at Novabiotics. HGF Patent Director Dr Lauris Kemp talked to Deborah about her career as a scientist and entrepreneur, how she got to where she is now, and lessons she has learned along the way.
To view the webinar please contact marketing@hgf.com
About Deborah
Deborah is a biotechnologist with over two decades of experience in the field of research & drug development.
Deborah founded NovaBiotics in 2004. She trained as an immunologist in internationally acclaimed laboratories (University College London, UC San Diego, University of Ghent) before moving to Aberdeen and developing the clinical and commercial potential of her antimicrobial technologies, spinning NovaBiotics out of the University of Aberdeen’s Rowett Research Institute.
Deborah is a Board member of the UK’s BioIndustry Association, a Director and founding member of the BEAM Alliance (Biotechs of Europe Innovating in Anti-Microbial Resistance), was a member of the Scottish Life Sciences Industry Leadership Group and served on the Boards of the Scottish Life Sciences Association and Opportunity North East Life Science/BioAberdeen. Also, Chairperson of the UK’s Medicines Discovery Catapult-Cystic fibrosis (CF) Trust’s working group on antimicrobials in CF and sits on the UK BioIndustry Association’s working group on AMR. Deborah was elected as a Fellow of the Royal Society of Edinburgh in 2018 and is a Fellow of the Royal Society of Medicine. Named as one of the 20 women leaders in European biotech in 2019, one of the 30 top female leaders in UK Healthcare in 2018, one of the 15 leading women in European biotech in 2017. In 2020, Deborah was made OBE in the Queen’s Birthday Honours list, for services to biotechnology, industry and charity.